![Patrick F. Cua](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patrick F. Cua
Chief Executive Officer at Glytec LLC
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Edmond L. Furlong | M | 60 |
Glytec LLC
![]() Glytec LLC Packaged SoftwareTechnology Services Part of Aseko, Inc., Glytec LLC is a healthcare provider company that specializes in improving the quality and cost of care for diabetes patients. The company, founded in 2006 by Robby Booth, is based in Waltham, MA, and has Edmond L. Furlong as its CEO since 2018. Glytec's FDA-cleared titration software and proprietary algorithms deliver personalized diabetes treatment recommendations across the continuum of care, from hospital to home. The company's eGlycemic Management System (eGMS) is an EHR-integrated cloud-based software solution that supports safe and effective glycemic management and insulin dosing. Glytec supports the transition from sliding scale to basal bolus insulin for standardization of insulin therapy across critical and non-critical care settings. The safety and efficacy of Glytec's solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences. | 6 years |
Andrew R. Midler | M | - |
Glytec LLC
![]() Glytec LLC Packaged SoftwareTechnology Services Part of Aseko, Inc., Glytec LLC is a healthcare provider company that specializes in improving the quality and cost of care for diabetes patients. The company, founded in 2006 by Robby Booth, is based in Waltham, MA, and has Edmond L. Furlong as its CEO since 2018. Glytec's FDA-cleared titration software and proprietary algorithms deliver personalized diabetes treatment recommendations across the continuum of care, from hospital to home. The company's eGlycemic Management System (eGMS) is an EHR-integrated cloud-based software solution that supports safe and effective glycemic management and insulin dosing. Glytec supports the transition from sliding scale to basal bolus insulin for standardization of insulin therapy across critical and non-critical care settings. The safety and efficacy of Glytec's solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences.
BioIQ, Inc.
![]() BioIQ, Inc. Packaged SoftwareTechnology Services BioIQ, Inc. develops and markets health screening and medical diagnostic platforms. It offers health improvement technologies, with focus on optimizing investments in corporate health and wellness programs. The firm's technology platform features the Dimensions, Axis, Ecosystem and Advisor components, serving as foundation for outcome-based wellness, performance measurement, population stratification and assignment of targeted health-improvement solutions based on each participant's actual risk. The company was founded by Justin J. Bellante and Raja Jindal in 2005 and is headquartered in Atlanta, GA. | - |
Sean Slovenski | M | - |
BioIQ, Inc.
![]() BioIQ, Inc. Packaged SoftwareTechnology Services BioIQ, Inc. develops and markets health screening and medical diagnostic platforms. It offers health improvement technologies, with focus on optimizing investments in corporate health and wellness programs. The firm's technology platform features the Dimensions, Axis, Ecosystem and Advisor components, serving as foundation for outcome-based wellness, performance measurement, population stratification and assignment of targeted health-improvement solutions based on each participant's actual risk. The company was founded by Justin J. Bellante and Raja Jindal in 2005 and is headquartered in Atlanta, GA. | 4 years |
Robby Booth | M | - |
Glytec LLC
![]() Glytec LLC Packaged SoftwareTechnology Services Part of Aseko, Inc., Glytec LLC is a healthcare provider company that specializes in improving the quality and cost of care for diabetes patients. The company, founded in 2006 by Robby Booth, is based in Waltham, MA, and has Edmond L. Furlong as its CEO since 2018. Glytec's FDA-cleared titration software and proprietary algorithms deliver personalized diabetes treatment recommendations across the continuum of care, from hospital to home. The company's eGlycemic Management System (eGMS) is an EHR-integrated cloud-based software solution that supports safe and effective glycemic management and insulin dosing. Glytec supports the transition from sliding scale to basal bolus insulin for standardization of insulin therapy across critical and non-critical care settings. The safety and efficacy of Glytec's solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences. | 18 years |
Michael Lester Cotton | M | 62 |
BioIQ, Inc.
![]() BioIQ, Inc. Packaged SoftwareTechnology Services BioIQ, Inc. develops and markets health screening and medical diagnostic platforms. It offers health improvement technologies, with focus on optimizing investments in corporate health and wellness programs. The firm's technology platform features the Dimensions, Axis, Ecosystem and Advisor components, serving as foundation for outcome-based wellness, performance measurement, population stratification and assignment of targeted health-improvement solutions based on each participant's actual risk. The company was founded by Justin J. Bellante and Raja Jindal in 2005 and is headquartered in Atlanta, GA. | 6 years |
Deborah L. Dean | F | - |
Glytec LLC
![]() Glytec LLC Packaged SoftwareTechnology Services Part of Aseko, Inc., Glytec LLC is a healthcare provider company that specializes in improving the quality and cost of care for diabetes patients. The company, founded in 2006 by Robby Booth, is based in Waltham, MA, and has Edmond L. Furlong as its CEO since 2018. Glytec's FDA-cleared titration software and proprietary algorithms deliver personalized diabetes treatment recommendations across the continuum of care, from hospital to home. The company's eGlycemic Management System (eGMS) is an EHR-integrated cloud-based software solution that supports safe and effective glycemic management and insulin dosing. Glytec supports the transition from sliding scale to basal bolus insulin for standardization of insulin therapy across critical and non-critical care settings. The safety and efficacy of Glytec's solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences. | 5 years |
Brandon W. Cady | M | - |
BioIQ, Inc.
![]() BioIQ, Inc. Packaged SoftwareTechnology Services BioIQ, Inc. develops and markets health screening and medical diagnostic platforms. It offers health improvement technologies, with focus on optimizing investments in corporate health and wellness programs. The firm's technology platform features the Dimensions, Axis, Ecosystem and Advisor components, serving as foundation for outcome-based wellness, performance measurement, population stratification and assignment of targeted health-improvement solutions based on each participant's actual risk. The company was founded by Justin J. Bellante and Raja Jindal in 2005 and is headquartered in Atlanta, GA. | - |
Mark J. Schwartz | M | - |
BioIQ, Inc.
![]() BioIQ, Inc. Packaged SoftwareTechnology Services BioIQ, Inc. develops and markets health screening and medical diagnostic platforms. It offers health improvement technologies, with focus on optimizing investments in corporate health and wellness programs. The firm's technology platform features the Dimensions, Axis, Ecosystem and Advisor components, serving as foundation for outcome-based wellness, performance measurement, population stratification and assignment of targeted health-improvement solutions based on each participant's actual risk. The company was founded by Justin J. Bellante and Raja Jindal in 2005 and is headquartered in Atlanta, GA. | - |
Danny R. Frank | M | 67 |
Glytec LLC
![]() Glytec LLC Packaged SoftwareTechnology Services Part of Aseko, Inc., Glytec LLC is a healthcare provider company that specializes in improving the quality and cost of care for diabetes patients. The company, founded in 2006 by Robby Booth, is based in Waltham, MA, and has Edmond L. Furlong as its CEO since 2018. Glytec's FDA-cleared titration software and proprietary algorithms deliver personalized diabetes treatment recommendations across the continuum of care, from hospital to home. The company's eGlycemic Management System (eGMS) is an EHR-integrated cloud-based software solution that supports safe and effective glycemic management and insulin dosing. Glytec supports the transition from sliding scale to basal bolus insulin for standardization of insulin therapy across critical and non-critical care settings. The safety and efficacy of Glytec's solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences. | - |
Paul McCreadie | M | - |
BioIQ, Inc.
![]() BioIQ, Inc. Packaged SoftwareTechnology Services BioIQ, Inc. develops and markets health screening and medical diagnostic platforms. It offers health improvement technologies, with focus on optimizing investments in corporate health and wellness programs. The firm's technology platform features the Dimensions, Axis, Ecosystem and Advisor components, serving as foundation for outcome-based wellness, performance measurement, population stratification and assignment of targeted health-improvement solutions based on each participant's actual risk. The company was founded by Justin J. Bellante and Raja Jindal in 2005 and is headquartered in Atlanta, GA. | - |
Regina Benjamin | M | 67 |
BioIQ, Inc.
![]() BioIQ, Inc. Packaged SoftwareTechnology Services BioIQ, Inc. develops and markets health screening and medical diagnostic platforms. It offers health improvement technologies, with focus on optimizing investments in corporate health and wellness programs. The firm's technology platform features the Dimensions, Axis, Ecosystem and Advisor components, serving as foundation for outcome-based wellness, performance measurement, population stratification and assignment of targeted health-improvement solutions based on each participant's actual risk. The company was founded by Justin J. Bellante and Raja Jindal in 2005 and is headquartered in Atlanta, GA. | - |
Peter Foley | M | - |
BioIQ, Inc.
![]() BioIQ, Inc. Packaged SoftwareTechnology Services BioIQ, Inc. develops and markets health screening and medical diagnostic platforms. It offers health improvement technologies, with focus on optimizing investments in corporate health and wellness programs. The firm's technology platform features the Dimensions, Axis, Ecosystem and Advisor components, serving as foundation for outcome-based wellness, performance measurement, population stratification and assignment of targeted health-improvement solutions based on each participant's actual risk. The company was founded by Justin J. Bellante and Raja Jindal in 2005 and is headquartered in Atlanta, GA. | - |
Erik Eaker | M | - |
BioIQ, Inc.
![]() BioIQ, Inc. Packaged SoftwareTechnology Services BioIQ, Inc. develops and markets health screening and medical diagnostic platforms. It offers health improvement technologies, with focus on optimizing investments in corporate health and wellness programs. The firm's technology platform features the Dimensions, Axis, Ecosystem and Advisor components, serving as foundation for outcome-based wellness, performance measurement, population stratification and assignment of targeted health-improvement solutions based on each participant's actual risk. The company was founded by Justin J. Bellante and Raja Jindal in 2005 and is headquartered in Atlanta, GA. | - |
Alfred Damus | M | - |
BioIQ, Inc.
![]() BioIQ, Inc. Packaged SoftwareTechnology Services BioIQ, Inc. develops and markets health screening and medical diagnostic platforms. It offers health improvement technologies, with focus on optimizing investments in corporate health and wellness programs. The firm's technology platform features the Dimensions, Axis, Ecosystem and Advisor components, serving as foundation for outcome-based wellness, performance measurement, population stratification and assignment of targeted health-improvement solutions based on each participant's actual risk. The company was founded by Justin J. Bellante and Raja Jindal in 2005 and is headquartered in Atlanta, GA. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Paula LeClair | F | - |
Glytec LLC
![]() Glytec LLC Packaged SoftwareTechnology Services Part of Aseko, Inc., Glytec LLC is a healthcare provider company that specializes in improving the quality and cost of care for diabetes patients. The company, founded in 2006 by Robby Booth, is based in Waltham, MA, and has Edmond L. Furlong as its CEO since 2018. Glytec's FDA-cleared titration software and proprietary algorithms deliver personalized diabetes treatment recommendations across the continuum of care, from hospital to home. The company's eGlycemic Management System (eGMS) is an EHR-integrated cloud-based software solution that supports safe and effective glycemic management and insulin dosing. Glytec supports the transition from sliding scale to basal bolus insulin for standardization of insulin therapy across critical and non-critical care settings. The safety and efficacy of Glytec's solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences. | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 15 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Patrick F. Cua
- Personal Network